NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Operating margin 2016–2021
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) operating margin by fiscal year — reported operating income divided by reported revenue.
-250080.0%FY2021 · since FY2016: -466.1% → -250080.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -250080.0% | -239976.6 pp |
| FY2020 | -10103.4% | -5646.9 pp |
| FY2019 | -4456.5% | +293.9 pp |
| FY2018 | -4750.4% | -90.2 pp |
| FY2017 | -4660.2% | -4194.1 pp |
| FY2016 | -466.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice